Seasonal influenza adapted and evolved during the COVID-19 pandemic

Although travel restrictions and social measures during the COVID-19 pandemic led to a dramatic global drop in seasonal influenza cases, certain influenza lineages in specific regions kept the virus circulating and evolving, according to a new study.

Novartis pays Monte Rosa $150M for Phase 1 drug in latest endorsement of molecular glues

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 29, 2024

Indoor fireplaces linked to harmful airborne particles and health risks

During the cold winter months, it is nice to light an indoor fireplace for extra warmth or to have the occasional ‘braai’. The downside is

August 1, 2024

Remote FDA drug inspections: New draft guidance spells out post-pandemic specifics

One of the FDA’s biggest tools from the pandemic is here to stay, and the agency released new draft guidance on how it plans to

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.